https://cardiooncology.be/ 2026-09-16T09:05:25+00:00 https://cardiooncology.be/wp-content/uploads/2026/01/Group-4.svg https://cardiooncology.be/wp-content/uploads/2026/01/Group-2.svg https://cardiooncology.be/wp-content/uploads/2026/01/Group-6.svg https://cardiooncology.be/wp-content/uploads/2026/01/Union-1.svg https://cardiooncology.be/wp-content/uploads/2026/01/Group-2.svg https://cardiooncology.be/wp-content/uploads/2026/01/Group-4.svg https://cardiooncology.be/wp-content/uploads/2026/01/Group-6.svg https://cardiooncology.be/wp-content/uploads/2026/01/Union-1.svg https://cardiooncology.be/wp-content/uploads/2026/07/about-us-1024x1018.png https://cardiooncology.be/wp-content/uploads/2026/07/news-1024x775.png https://cardiooncology.be/login/ 2025-12-31T08:38:33+00:00 https://cardiooncology.be/important-documents/ 2026-06-19T09:39:07+00:00 https://cardiooncology.be/patients/ 2026-09-10T09:34:16+00:00 https://cardiooncology.be/wp-content/uploads/2026/05/ESC-Patient-Guidelines-Cardio-Oncology-EN_page-0001-725x1024.jpg https://cardiooncology.be/wp-content/uploads/2026/05/ESC-CVD-prevention-guidelines-EN_page-0001-725x1024.jpg https://cardiooncology.be/wp-content/uploads/2026/05/ESC-Patient-Guidelines-Cardio-Oncology-EN_page-0001-725x1024.jpg https://cardiooncology.be/wp-content/uploads/2026/05/ESC-CVD-prevention-guidelines-EN_page-0001-725x1024.jpg https://cardiooncology.be/common-cardiovascular-problems/ 2026-09-16T09:01:17+00:00 https://cardiooncology.be/basic-cv-risk-assessment/ 2026-09-16T09:06:20+00:00 https://cardiooncology.be/patients-fr/ 2026-09-16T09:22:33+00:00 https://cardiooncology.be/wp-content/uploads/2026/09/ESC-Patient-Guidelines-Cardio-Oncology-FR-726x1024.jpg https://cardiooncology.be/wp-content/uploads/2026/09/ESC-CVD-prevention-guidelines-FR-724x1024.jpg https://cardiooncology.be/wp-content/uploads/2026/09/ESC-Patient-Guidelines-Cardio-Oncology-FR-726x1024.jpg https://cardiooncology.be/wp-content/uploads/2026/09/ESC-CVD-prevention-guidelines-FR-724x1024.jpg https://cardiooncology.be/patients-nl/ 2026-09-16T09:25:06+00:00 https://cardiooncology.be/wp-content/uploads/2026/09/ESC-Patient-Guidelines-Cardio-Oncology-NL-726x1024.jpg https://cardiooncology.be/wp-content/uploads/2026/09/ESC-CVD-prevention-guidelines-NL-724x1024.jpg https://cardiooncology.be/wp-content/uploads/2026/09/ESC-Patient-Guidelines-Cardio-Oncology-NL-726x1024.jpg https://cardiooncology.be/wp-content/uploads/2026/09/ESC-CVD-prevention-guidelines-NL-724x1024.jpg https://cardiooncology.be/toxicities-per-treatment/endocrine-therapy-women/ 2026-09-19T20:47:31+00:00 https://cardiooncology.be/contact/ 2026-09-19T21:00:31+00:00 https://cardiooncology.be/toxicities-per-treatment/ 2026-09-30T12:55:09+00:00 https://cardiooncology.be/toxicities-per-treatment/tki/ 2026-09-30T12:57:34+00:00 https://cardiooncology.be/news-events/ 2026-09-30T13:01:05+00:00 https://cardiooncology.be/wp-content/uploads/2026/06/Afbeelding2-1024x1024.png https://cardiooncology.be/about-us/ 2026-10-04T22:19:30+00:00 https://cardiooncology.be/wp-content/uploads/2023/03/Cardio-Oncology_LOGO_Cardio-Oncology_Icon.svg https://cardiooncology.be/wp-content/uploads/2026/07/beone_primary_logo_RGB_M02_V01-removebg-preview.png https://cardiooncology.be/wp-content/uploads/2026/07/AstraZeneca-Logo-1024x576.png https://cardiooncology.be/wp-content/uploads/2026/07/Novartis-Logo.svg.webp https://cardiooncology.be/wp-content/uploads/2026/07/Pfizer_Logo_Color_RGB-1024x423.png https://cardiooncology.be/wp-content/uploads/2026/07/Boehringer_Ingelheim_Logo.svg-1024x318.webp https://cardiooncology.be/toxicities-per-treatment/tki/btk-inhibitors/ 2026-10-06T09:24:46+00:00 https://cardiooncology.be/wp-content/uploads/2026/04/Picture2-1-1024x424.jpg https://cardiooncology.be/toxicities-per-treatment/tki/bcr-abl-inhibitors/ 2026-10-06T09:27:17+00:00 https://cardiooncology.be/wp-content/uploads/2026/04/ehac244f16-scaled.jpeg https://cardiooncology.be/wp-content/uploads/2026/04/ehac244f17-scaled.jpeg https://cardiooncology.be/wp-content/uploads/2026/04/m_ehac244table11.jpeg https://cardiooncology.be/toxicities-per-treatment/tki/alk-and-egfr-inhibitors/ 2026-10-06T09:27:30+00:00 https://cardiooncology.be/toxicities-per-treatment/anthracyclines/ 2026-10-06T09:28:01+00:00 https://cardiooncology.be/wp-content/uploads/2026/04/ehac244f12-999x1024.jpeg https://cardiooncology.be/wp-content/uploads/2026/04/Picture3-1-1024x544.jpg https://cardiooncology.be/toxicities-per-treatment/anti-her-2-targeted-therapies/ 2026-10-06T09:28:15+00:00 https://cardiooncology.be/wp-content/uploads/2026/04/ehac244f13-1024x922.jpeg https://cardiooncology.be/wp-content/uploads/2026/04/Picture4-1024x633.jpg https://cardiooncology.be/toxicities-per-treatment/antimetabolites/ 2026-10-06T09:28:25+00:00 https://cardiooncology.be/wp-content/uploads/2026/04/m_ehac244table9.jpeg https://cardiooncology.be/toxicities-per-treatment/other-chemotherapeutic-agents/ 2026-10-06T09:28:37+00:00 https://cardiooncology.be/toxicities-per-treatment/immune-checkpoint-inhibitors/ 2026-10-06T09:28:48+00:00 https://cardiooncology.be/wp-content/uploads/2026/04/ehac244f22-1024x1024.jpeg https://cardiooncology.be/wp-content/uploads/2026/04/Picture6-1024x361.jpg https://cardiooncology.be/toxicities-per-treatment/angiogenesis-inhibitors/ 2026-10-06T09:29:04+00:00 https://cardiooncology.be/wp-content/uploads/2026/04/ehac244f14-768x701.jpeg https://cardiooncology.be/wp-content/uploads/2026/04/ehac244f15-997x1024.jpeg https://cardiooncology.be/wp-content/uploads/2026/04/Picture7-1024x648.jpg https://cardiooncology.be/toxicities-per-treatment/endocrine-therapy-men/ 2026-10-06T09:29:35+00:00 https://cardiooncology.be/toxicities-per-treatment/radiation-therapy/ 2026-10-06T09:29:42+00:00 https://cardiooncology.be/wp-content/uploads/2026/04/circimaging.124.017454.fig01-1024x566.jpg https://cardiooncology.be/wp-content/uploads/2026/04/m_ehac244table21.jpeg https://cardiooncology.be/wp-content/uploads/2026/04/ehac244f25-1024x1024.jpeg https://cardiooncology.be/wp-content/uploads/2026/04/1-s2.0-S2666087321001496-gr1_lrg-1024x827.jpg https://cardiooncology.be/wp-content/uploads/2026/04/ehac244f46-1024x1024.jpeg https://cardiooncology.be/wp-content/uploads/2026/04/ehac244f47-997x1024.jpeg https://cardiooncology.be/wp-content/uploads/2026/04/ehac244f48-997x1024.jpeg https://cardiooncology.be/toxicities-per-treatment/stem-cell-transplantation/ 2026-10-06T09:29:49+00:00 https://cardiooncology.be/wp-content/uploads/2026/04/ehac244f26-997x1024.jpeg https://cardiooncology.be/toxicities-per-treatment/cellular-immune-therapies-car-t-tils-bites/ 2026-10-06T09:29:58+00:00 https://cardiooncology.be/wp-content/uploads/2026/04/m_ehac244table20.jpeg https://cardiooncology.be/toxicities-per-treatment/proteasome-inhibitors/ 2026-10-06T09:30:06+00:00 https://cardiooncology.be/wp-content/uploads/2026/04/ehac244f18-1024x969.jpeg https://cardiooncology.be/wp-content/uploads/2026/04/ehac244f19-997x1024.jpeg https://cardiooncology.be/wp-content/uploads/2026/04/Picture8-scaled.jpg https://cardiooncology.be/toxicities-per-treatment/immunomodulatory-drugs/ 2026-10-06T09:30:14+00:00 https://cardiooncology.be/toxicities-per-treatment/other-targeted-therapies/ 2026-10-06T09:30:22+00:00 https://cardiooncology.be/common-cardiovascular-problems/ctr-cvt-definitions/ 2026-10-06T09:30:50+00:00 https://cardiooncology.be/common-cardiovascular-problems/anthracycline-chemotherapy-related-cardiac-dysfunction-ctrcd/ 2026-10-06T09:30:59+00:00 https://cardiooncology.be/wp-content/uploads/2026/04/ehac244f12-1-999x1024.jpeg https://cardiooncology.be/wp-content/uploads/2026/04/ehac244f27-997x1024.jpeg https://cardiooncology.be/common-cardiovascular-problems/her2-targeted-therapy-related-cardiac-dysfunction-ctrcd/ 2026-10-06T09:31:11+00:00 https://cardiooncology.be/wp-content/uploads/2026/04/her2-targeted-therapy-surveillance-protocol-1024x922.webp https://cardiooncology.be/wp-content/uploads/2026/04/ehac244f28-997x1024.jpeg https://cardiooncology.be/common-cardiovascular-problems/arterial-hypertension/ 2026-10-06T09:31:19+00:00 https://cardiooncology.be/wp-content/uploads/2026/04/ehac244f35-1024x1024.jpeg https://cardiooncology.be/common-cardiovascular-problems/atrial-fibrillation-af/ 2026-10-06T09:31:26+00:00 https://cardiooncology.be/wp-content/uploads/2026/06/Afbeelding1-1.jpg https://cardiooncology.be/wp-content/uploads/2026/09/ehac244f31a-923x1024.jpeg https://cardiooncology.be/wp-content/uploads/2026/09/fx1-2.jpg https://cardiooncology.be/common-cardiovascular-problems/qtc-prolongation-and-ventricular-arrhythmias/ 2026-10-06T09:31:37+00:00 https://cardiooncology.be/wp-content/uploads/2026/04/ehac244f34-863x1024.jpeg https://cardiooncology.be/common-cardiovascular-problems/bradyarrhythmias/ 2026-10-06T09:31:45+00:00 https://cardiooncology.be/common-cardiovascular-problems/acute-coronary-syndrome-acs/ 2026-10-06T09:32:22+00:00 https://cardiooncology.be/common-cardiovascular-problems/chronic-coronary-artery-disease-cad/ 2026-10-06T09:32:30+00:00 https://cardiooncology.be/common-cardiovascular-problems/pericardial-diseases/ 2026-10-06T09:33:08+00:00 https://cardiooncology.be/common-cardiovascular-problems/takotsubo-syndrome-tts/ 2026-10-06T09:33:16+00:00 https://cardiooncology.be/wp-content/uploads/2026/04/ehac244f31-997x1024.jpeg https://cardiooncology.be/wp-content/uploads/2026/04/ehac244table27-768x490.jpeg https://cardiooncology.be/common-cardiovascular-problems/cancer-associated-thrombosis-cat-and-venous-thrombembolism-vte/ 2026-10-06T09:33:26+00:00 https://cardiooncology.be/wp-content/uploads/2026/09/Picture1.jpg https://cardiooncology.be/toxicities-per-treatment/endocrine-therapy-women/aromatase-inhibitors-ai-and-selective-estrogen-receptor-modulators-serm/ 2026-10-06T09:37:33+00:00 https://cardiooncology.be/wp-content/uploads/2026/04/Impact-of-Hormonal-Therapies-for-the-Treatment-of-Hormone-Dependent-Cancers--1024x682.webp https://cardiooncology.be/wp-content/uploads/2026/04/guidlines-832x1024.webp https://cardiooncology.be/toxicities-per-treatment/endocrine-therapy-women/gonadotropin-releasing-hormone-gnrh-agonists/ 2026-10-06T09:38:25+00:00 https://cardiooncology.be/wp-content/uploads/2026/04/Picture4-1.jpg https://cardiooncology.be/wp-content/uploads/2026/04/guideline-4-765x1024.webp https://cardiooncology.be/toxicities-per-treatment/endocrine-therapy-men/gonadotropin-releasing-hormone-gnrh-antagonists/ 2026-10-06T09:39:26+00:00 https://cardiooncology.be/wp-content/uploads/2026/09/GnrHa-antagonist.jpg https://cardiooncology.be/wp-content/uploads/2026/04/guideline-5-765x1024.webp https://cardiooncology.be/toxicities-per-treatment/endocrine-therapy-men/androgen-receptor-targeted-agents-arta/ 2026-10-06T09:39:46+00:00 https://cardiooncology.be/wp-content/uploads/2026/09/arta.jpg https://cardiooncology.be/wp-content/uploads/2026/04/guideline-1-764x1024.webp https://cardiooncology.be/toxicities-per-treatment/other-targeted-therapies/raf-and-mek-inhibitors/ 2026-10-06T09:40:18+00:00 https://cardiooncology.be/wp-content/uploads/2026/04/ehac244f21-scaled.jpeg https://cardiooncology.be/wp-content/uploads/2026/04/ehac244table14.jpeg https://cardiooncology.be/toxicities-per-treatment/other-targeted-therapies/breast-cancer-tki/ 2026-10-06T09:40:27+00:00 https://cardiooncology.be/wp-content/uploads/2026/04/Picture3-2-1024x591.jpg https://cardiooncology.be/toxicities-per-treatment/other-targeted-therapies/hematological-antibody-drug-conjugates/ 2026-10-06T09:40:48+00:00 https://cardiooncology.be/common-cardiovascular-problems/immune-chekpoint-inhibitor-ici-related-myocarditis/ 2026-10-06T09:42:00+00:00 https://cardiooncology.be/wp-content/uploads/2026/04/direved-risk-score-1024x708.webp https://cardiooncology.be/wp-content/uploads/2026/09/Screenshot-2026-09-05-212543.png https://cardiooncology.be/wp-content/uploads/2026/10/Picture4.jpg https://cardiooncology.be/wp-content/uploads/2026/10/fulminant-ICI-1-1024x985.jpg https://cardiooncology.be/wp-content/uploads/2026/10/ICI-management-1024x589.jpg https://cardiooncology.be/privacy/ 2026-10-09T07:17:32+00:00 https://cardiooncology.be/cookie-policy-eu/ 2026-10-09T07:19:04+00:00